Ecuador vs New Zealand: New cases tested for RR-/MDR-TB
Ecuador
100.0%
in 2024
New Zealand
100.0%
in 2014
Ecuador rank
1st
New Zealand rank
1st
New cases tested for RR-/MDR-TB over time
- Ecuador
- New Zealand
How they compare
Ecuador currently reports 100.0% against 100.0% in New Zealand, a difference of 0.0%.
Across all 8 years both countries report, New Zealand has been ahead every year.
Ecuador ranks 1st and New Zealand ranks 1st of 192 countries.
New Zealand has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Ecuador | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.4% | 100.0% | 96.6% | New Zealand |
| 2010s | 17.7% | 80.5% | 62.8% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Ecuador or New Zealand?
- Ecuador, at 100.0% against 100.0% in New Zealand as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Ecuador and New Zealand?
- 0.0%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and New Zealand?
- 8 years are reported by both, from 2005 to 2014.
- How do Ecuador and New Zealand rank globally for new cases tested for rr-/mdr-tb?
- Ecuador ranks 1st and New Zealand ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.